The Adoption of Medications in Substance Abuse Treatment: Associations With Organizational Characteristics

Simple item page
dc.contributor.authorLewis, Deannaen
dc.coverage.spatialUnited Statesen
dc.date.accessioned2010-03-31T15:51:31Z
dc.date.accessioned2024-07-23T20:54:35Z
dc.date.available2010-03-31T15:51:31Z
dc.date.available2024-07-23T20:54:35Z
dc.date.issued2008-02en
dc.description.abstractHighlights findings from a study of the use of phamacotherapies to treat substance abuse and the factors that affect their adoption by treatment organizations. Analyzes patterns by type of medication, type of organization, and accreditation.en
dc.identifier.citationhttp://www.rwjf.org/files/research/researchhighlight2027.2.pdfen
dc.identifier.otherfdc82000024en
dc.identifier.urihttps://hdl.handle.net/10244/604
dc.language.isoen_USen
dc.publisherRobert Wood Johnson Foundationen
dc.publisher.fundingsourcesRobert Wood Johnson Foundationen
dc.subjectSubstance Abuseen
dc.subjectHealthen
dc.subjectHealth, Healthcare Access/Reformen
dc.titleThe Adoption of Medications in Substance Abuse Treatment: Associations With Organizational Characteristicsen
dc.typeIssue Briefsen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
researchhighlight2027.2.pdf
Size:
98.79 KB
Format:
Adobe Portable Document Format
Download
Collections
FOundation LIterature Online